In addition, the TG, FBG, and insulin levels in the obesity subgroup were significantly higher than those in the normal weight subgroup (Table 4), suggesting a positive correlation between body weight/BMI and TG, FBG, or insulin in olanzapine-treated schizophrenia patients. Here, INS is linked to schizophrenia.